These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17234981)

  • 1. Previous antiplatelet treatment and mortality in patients with intracerebral hemorrhage.
    Roquer J
    Stroke; 2007 Mar; 38(3):863; author reply 864. PubMed ID: 17234981
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence against rapid reversal of antiplatelet medications in acute intracerebral hemorrhage.
    Broderick JP
    Neurology; 2009 Apr; 72(16):1376-7. PubMed ID: 19129503
    [No Abstract]   [Full Text] [Related]  

  • 3. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
    van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ;
    Trials; 2015 Sep; 16():393. PubMed ID: 26340977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic pretreatment increases very-early mortality in primary intracerebral hemorrhage.
    Roquer J; Vivanco Hidalgo RM; Ois A; Rodríguez Campello A; Cuadrado Godia E; Giralt Steinhauer E; Gómez González A; Soriano-Tarraga C; Jiménez Conde J
    Neurology; 2017 Feb; 88(9):885-891. PubMed ID: 28148636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet use after intracerebral hemorrhage.
    Viswanathan A; Rakich SM; Engel C; Snider R; Rosand J; Greenberg SM; Smith EE
    Neurology; 2006 Jan; 66(2):206-9. PubMed ID: 16434655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does antiplatelet therapy at the time of intracerebral hemorrhage bode poor outcome?
    Lovelock CE; Rothwell PM
    Neurology; 2010 Oct; 75(15):1314-5. PubMed ID: 20844242
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage.
    Toyoda K; Okada Y; Minematsu K; Kamouchi M; Fujimoto S; Ibayashi S; Inoue T
    Neurology; 2005 Oct; 65(7):1000-4. PubMed ID: 16217049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of on-admission antiplatelet treatment on patients with cerebral hemorrhage.
    Caso V; Paciaroni M; Venti M; Alberti A; Palmerini F; Milia P; Billeci AM; Silvestrelli G; Biagini S; Agnelli G
    Cerebrovasc Dis; 2007; 24(2-3):215-8. PubMed ID: 17630480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain microbleeds as a potential risk factor for antiplatelet-related intracerebral haemorrhage.
    Leys D; Cordonnier C
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):589-90. PubMed ID: 20522865
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiple cerebral haemorrhages and antiplatelet drugs].
    Rubí-Callejón J; Arjona A; Serrano-Castro PJ
    Rev Neurol; 2004 Sep 16-30; 39(6):600; author reply 600. PubMed ID: 15468007
    [No Abstract]   [Full Text] [Related]  

  • 11. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review.
    Naidech AM; Batjer HH; Bernstein RA
    Neurology; 2011 May; 76(18):1607. PubMed ID: 21536645
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intracerebral hemorrhage caused by oral anticoagulant, oral antiplatelet and intravenous tissue plasminogen activator therapy].
    Yoshida Y
    Nihon Rinsho; 2006 Nov; 64 Suppl 8():531-4. PubMed ID: 17469605
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiplatelet and anticoagulant therapy after intracerebral hemorrhage.
    Zazulia A
    Neurol Clin; 2015 May; 33(2):329-45. PubMed ID: 25907909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortality.
    Lacut K; Le Gal G; Seizeur R; Prat G; Mottier D; Oger E
    Fundam Clin Pharmacol; 2007 Jun; 21(3):327-33. PubMed ID: 17521302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage.
    Foerch C; Sitzer M; Steinmetz H; Neumann-Haefelin T
    Stroke; 2006 Aug; 37(8):2165-7. PubMed ID: 16809556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy influences location, enlargement, and mortality from intracerebral hemorrhage. The Bleeding with Antithrombotic Therapy (BAT) Retrospective Study.
    Toyoda K; Yasaka M; Nagata K; Nagao T; Gotoh J; Sakamoto T; Uchiyama S; Minematsu K;
    Cerebrovasc Dis; 2009; 27(2):151-9. PubMed ID: 19039219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple electrode aggregometry in antiplatelet-related intracerebral haemorrhage.
    Beynon C; Sakowitz OW; Unterberg AW
    J Clin Neurosci; 2013 Dec; 20(12):1805-6. PubMed ID: 23830689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benefits and risks of antiplatelet therapy. A retrospective study].
    Nishimaru K; Yamaguchi T
    Nihon Rinsho; 1992 Feb; 50(2):392-6. PubMed ID: 1613996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobar intracerebral haemorrhage: analysis of a series and characteristics of patients receiving antiplatelet or anticoagulation treatment.
    Romero López J; Maciñeiras Montero JL; Fontanillo Fontanillo M; Escriche Jaime D; Moreno Carretero MJ; Corredera García E
    Neurologia; 2012 Sep; 27(7):387-93. PubMed ID: 22018825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anticoagulant and antiplatelet therapy in patients with spontaneous intra-cerebral hemorrhage: Does medication use predict worse outcome?
    Stead LG; Jain A; Bellolio MF; Odufuye AO; Dhillon RK; Manivannan V; Gilmore RM; Rabinstein AA; Chandra R; Serrano LA; Yerragondu N; Palamari B; Decker WW
    Clin Neurol Neurosurg; 2010 May; 112(4):275-81. PubMed ID: 20042270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.